Aortic calcified plaques and cardiovascular disease (the Framingham Study)

Area of Science:

• Cardiovascular Medicine
• Radiology
• Epidemiology

Background:

• Cardiovascular disease (CVD) remains a leading cause of mortality worldwide.
• Atherosclerosis, a key contributor to CVD, involves plaque buildup in arteries.
• The predictive value of thoracic aortic calcification (TAC) for future CVD events requires further elucidation.

Purpose of the Study:

• To investigate the association between the presence of TAC on chest X-rays and the incidence of cardiovascular disease.
• To assess the risk of cardiovascular death, coronary artery disease, stroke, and intermittent claudication in relation to TAC.
• To determine how the predictive value of TAC for CVD risk changes with age.

Main Methods:

• Analysis of 12-year follow-up data from the Framingham cohort (n=5,209).
• Assessment of thoracic aortic calcified plaques using chest X-rays.
• Statistical analysis to evaluate the association between TAC and CVD events, adjusting for traditional risk factors.

Main Results:

• Prevalence of TAC doubled with each decade of age.
• TAC presence was associated with a twofold increased risk of cardiovascular death in individuals younger than 65, independent of other risk factors.
• Similar risk increases for coronary artery disease, stroke, and intermittent claudication were observed in middle-aged women, with less marked risks in men.
• The predictive value of TAC diminished with age, with a sevenfold increased risk of sudden coronary death at age 35, diminishing to no excess risk at age 70.

Conclusions:

• TAC is a significant predictor of future cardiovascular events, particularly in younger individuals.
• The findings support the concept of atherosclerosis as a systemic process.
• Routine chest X-rays revealing TAC in younger patients may serve as an early warning sign for potential future atherosclerotic disease in the cardiac, cerebral, and peripheral circulations.